Zynerba Pharmaceuticals to Present at 28th Annual ROTH Conference

DEVON, Pa., March 7, 2016 – Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that the Company will present at the 28th Annual ROTH Conference. The conference will be held March 13 to 16, at The Ritz Carlton Hotel in Dana Point, CA. Zynerba Chairman and CEO Armando Anido will present on Monday, March 14, at 11:00 am Pacific time.

Click here to read the full press release.


©2017 PACT All Rights Reserved